AIL
REGN icon

Atomic Invest LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

Atomic Invest LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$515 Buy
+1
New +$679 ﹤0.01% 299

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Atomic Invest LLC's REGN Position: Q4 2025 in Review

Atomic Invest LLC opened a new position in Regeneron Pharmaceuticals (REGN) in Q4 2025: 1 share worth $515. The stake represents ﹤0.01% of the portfolio and ranks #299 among its holdings.

1,389 funds tracked by Wall St. Rank hold REGN as of Q4 2025.

  • Atomic Invest LLC held 1 share of Regeneron Pharmaceuticals worth $515 as of Q4 2025.
  • Regeneron Pharmaceuticals was a new Atomic Invest LLC position in Q4 2025.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Atomic Invest LLC's portfolio in Q4 2025, its #299 holding.
  • 1,389 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.

Based on Atomic Invest LLC's 13F filing for Q4 2025, filed 18 Sep 2026.